
But their evidence validates, to a degree, industry's claim that coupons are not generics killers

But their evidence validates, to a degree, industry's claim that coupons are not generics killers

Regulatory compliance remains the top concern globally, but security and spoilage are high in the Asia/Pacific region

New service launched by WEGO Health offers rapid feedback from key opinion influencers in consumer healthcare



Highly automated facility can process 50 million prescriptions annually for CVS Caremark's book of business

IAG Cargo's Heathrow facility is up and running; FedEx has begun construction of a facility at its Memphis hub



Retailers, distributors and manufacturers are being affected by federal rules on durable medical equipment (DME)

Blue Cross/Blue Shield PBM says seven steps help manage costs

Exhibition brings out the latest in temperature-controlled shipping

Bill includes voluntary oversight by FDA of outsourced compounded pharmaceuticals, national distributor licensure, and a timetable for serialization and drug tracking

The Medicare Part D switchover of 2007 is only a partial proxy for what the healthcare system will experience in the next several years

Results of a survey panel by QPharma, presented at PDMA Sharing Conference, show a wide spread of reactions and concerns over agg-spend rules

UDIs will be in place starting in late 2014, and rolling out over the next four years thereafter

While FDA dithers on regulatory guidance, state efforts to anticipate biosimilar regulation are mostly being rejected

The size of clinical trials continues to expand, observers say, creating a ripple effect in pharmaceutical packaging.

While riding the same downturn as overall pharma sales-rep headcount, contract sales organizations (CSOs) have invested in IT competency and marketing services to meet client needs


Industry response may be to keep more innovations as trade secrets

New approaches, and new skill sets are necessary for meeting the challenges of global drug reimbursement policies


While pharma manufacturers may be concerned about the impact of item-level inventory tracking, it's an idea that actually makes great business sense